Ken Frazier
CEO
Management
Merck Sharp & Dohme de España, S.A.
Spain
Biography
Kenneth C. Frazier is the chairman of the board and chief executive officer, Merck & Co., Inc. Director, Exxon Mobil and PhRMA. Member, Board of Overseers, Weill Cornell Medicine. Trustee, Cornerstone Christian Academy. Our director since Jan. 1, 2011. Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the second African-American to lead a major pharmaceutical company.
Research Interest
His area of research interest includes Business Management and technology, Medical Marketing Services in pharmaceutical technologies
